Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
33%
Ph phase_1
1
33%
Ph phase_4
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 41 (33.3%)

Trials by Status

recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_4

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

NCT05365425
completedphase_2

Effect of Choline Fenofibrate (SLV348) on Macular Edema

NCT00683176
completedphase_1

ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study

NCT00673881

Clinical Trials (3)

Showing 3 of 3 trials
NCT05365425Phase 4

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Recruiting
NCT00683176Phase 2

Effect of Choline Fenofibrate (SLV348) on Macular Edema

Completed
NCT00673881Phase 1

ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3